ArticleCancer research and treatment2015

Clinical Significance of Non-neutropenic Fever in the Management of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP: Comparison with Febrile Neutropenia and Risk Factor Analysis.

Silvia Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.